These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2436776)

  • 1. Correlation between tumor markers and tumor size.
    Kobayashi T
    Cancer Detect Prev; 1987; 10(1-2):81-7. PubMed ID: 2436776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers in melanoma].
    Morsches B; Prellwitz W; Benes P; Schramm P; Trumpfheller R; Korting GW
    Dermatol Monatsschr; 1984; 170(6):380-90. PubMed ID: 6205909
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum ferritin in patients with malignant neoplasms].
    Hoshi H; Nakayama S; Kodama T; Jinnouchi S; Nishikawa K; Wakuta Y; Kakitsubata Y; Kusuhara T; Watanabe K
    Radioisotopes; 1983 Jan; 32(1):13-7. PubMed ID: 6190199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer.
    Cunietti E; Locatelli E; Vaiani G; Gandini R; Gandini MC; Reggiani A; Monti M
    Cancer Detect Prev; 1985; 8(1-2):227-32. PubMed ID: 4064042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of sialic acid as a tumor marker].
    Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers in rectal cancer].
    Ozhiganov EL; Kuznetsova LF
    Med Radiol (Mosk); 1985 Jul; 30(7):21-5. PubMed ID: 2410758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of biochemical tumor markers (CEA, Ca 19-9, ferritin and sialic acid) in diagnosis and prognosis of colonic neoplasms].
    Krasnodebski IW
    Wiad Lek; 1998; 51(3-4):132-41. PubMed ID: 9658987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
    Dalifard I; Daver A; Cellier P; Larra F
    Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
    Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
    J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CEA, HCG-beta and alpha fetoproteins - clinical significance as tumor markers].
    Nagel R; Borgmann V; Kemper JD
    Helv Chir Acta; 1981 Aug; 48(3-4):433-43. PubMed ID: 6169686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of radioassays for calcitonin, CEA-S, AFP and ferritin as tumor markers (author's transl)].
    Morita R; Yoshii M
    Rinsho Hoshasen; 1979 Jul; 24(7):755-61. PubMed ID: 90180
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of neopterin determination as a tumour marker in ovarian cancer.
    Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.